Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential

Blood Cells, Molecules, and Diseases

Volumn 22, Issue 1, 1996, Pages 68-81

  Srour, Edward F ^a   Bregni, Marco ^b   Traycoff, Christie M ^a   Agüero, Bibiana ^c   Kosak, Steven T ^a   Hoffman, Ronald ^a   Siena, Salvatore ^b   Gianni, A Massimo ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c AMGEN INC   (United States)

Author keywords

Ex vivo expansion; Mobilized peripheral blood CD34+

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; IFOSFAMIDE; MILODISTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3;

ARTICLE; BONE MARROW CELL; CANCER PATIENT; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOBILIZATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; TISSUE GRAFT; UMBILICAL CORD BLOOD;

EID: 0030130750     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1996.0010     Document Type: Article

References (38)

1. 1. Bregni M, Siena S, Magni M, Bonadonna G, Gianni AM. Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma. Leukemia 1:123-127, 1991.
2. 2. Bregni M, Siena S, Bonadonna G, Gianni AM. Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF). Eur J Cancer 2:235-238, 1994.
3. 3. Gianni AM, Siena S, Bregni M. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood [letter; comment]. Exp Hematol 19:147-148, 1991.
4. 4. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658, 1995.
5. 5. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659-1665, 1995.
6. 6. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-409, 1991.
7. 7. Gianni AM, Siena S, Bregni M, et al. Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy. Ann Oncol 4:759-766, 1993.
8. 8. Tong J, Hoffman R, Siena S, Srour EF, Bregni M, Gianni AM. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts. Exp Hematol 22:1016-1024, 1994.
9. + cells. Blood 84:2930-2939, 1994.
10. + progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor. Exp Hematol 22:990-995, 1994.
11. 11. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418-1422, 1992.
12. 12. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 9:277-284, 1992
13. 13. Reiffers J, Faberes C, Boiron JM, et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. Journal of Hematotherapy 3:185-191, 1994.
14. 14. Siena S, Bregni M, Bonsi L, et al. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Exp Hematol 21:1583-1590, 1993.
15. 15. Tarella C, Ferrero D, Bregni M, et al. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 27:22-27, 1991.
16. + selected human peripheral blood progenitor cells. Blood 84:2898-2903, 1994.
17. 17. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE. Kinetics of commited and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 83:3808-3814, 1994.
18. + cells expanded in vitro. Exp Hematol 22:1171-1178, 1994.
19. 19. Traycoff CM, Abboud MR, Laver J, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 22:215-222, 1994.
20. 20. Traycoff CM, Kosak ST, Grigsby S, Srour EF. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85:2059-2068, 1995.
21. 21. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614-1619, 1981.
22. 22. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563-1570, 1989.
23. 23. Brandt JE, Baird N, Lu L, Srour E, Hoffman R. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 82:1017-1027, 1988.
24. 24. Reisner Y, Kirkpatrick D, Dupont B, et al. Transplantation for acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 2:327-331, 1981.
25. 25. Gale RP, Reiffers J, Juttner CA. What's new in blood progenitor cell auto transplants? Bone Marrow Transplant. 14:343-346, 1994.
26. 26. Ossenkoppele GJ, Jonkhoff AR, Huijgens PC, et al. Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma. Bone Marrow Transplant. 13:37-41, 1994.
27. 27. Brandt J, Srour EF, vanBesien K, Briddell RA, Hoffman R. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 86:932-941, 1990.
28. 28. Verfaillie C, Blakolmer K, McGlave P. Purified human hematopoietic progenitor cells with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172:509-522, 1990.
29. 29. Moritz T, Patel V, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451-1457, 1994.
30. 30. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D. Efficient retro virus transduction of murine pluripotent hematopoietic stem cells mobilized into peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482-1491, 1994.
31. 31. Pettengell R, Testa NG, Swindell R, Crowther D, Dexter M. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239-2248, 1993.
32. 32. Breems DA, Blokland EA, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8:1095-1104, 1994.
33. + CD45RA-hematopoietic progenitors isolated from mobilized peripheral blood. Blood 84:104a, 1994.
34. 34. Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ. Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513-2521, 1992.
35. + cells from patients with stage IV breast cancer. Blood 84:3567-3574, 1994.
36. + cells an enhanced ex vivo expansion potential. Exp Hematol 22:1264-1272, 1994.
37. 37. Danova M, Rosti V, Mazzini G, et al. Proliferative activity of bone marrow versus peripheral blood CD34-positive cells on steady state and following chemotherapy plus G-CSF. Blood 84:23a, 1994.
38. + progenitor cells correlates with the number of cellular divisions in culture. Blood 84:267a, 1994.